dr. o'donnell compares checkpoint inhibitors in bladder cancer
Published 5 years ago • 107 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
2:07
dr. o’donnell on the evolution of immunotherapy in metastatic bladder cancer
-
1:12
dr. o’donnell on ongoing immunotherapy trials in bladder cancer
-
1:26
dr linscott on future directions for utdna research in bladder cancer
-
1:35
dr. plimack on choosing a checkpoint inhibitor in bladder cancer
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
1:13:04
urowebinar: developments in perioperative immunotherapy for bladder and kidney cancers
-
22:58
2024 asco genitourinary bladder cancer highlights
-
8:26
how does immunotherapy work? – bladder cancer immunotherapy animation
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
6:00
use of immune checkpoint inhibitors for bladder cancer
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
4:51
practical considerations with checkpoint inhibitors in bladder cancer
-
1:06
dr. gulley on checkpoint inhibitors in bladder cancer
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer